CH612195A5 - - Google Patents

Info

Publication number
CH612195A5
CH612195A5 CH1675474A CH1675474A CH612195A5 CH 612195 A5 CH612195 A5 CH 612195A5 CH 1675474 A CH1675474 A CH 1675474A CH 1675474 A CH1675474 A CH 1675474A CH 612195 A5 CH612195 A5 CH 612195A5
Authority
CH
Switzerland
Application number
CH1675474A
Inventor
Juergen Dr Seubert
Herbert Dr Thomas
Peter Dr Andrews
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5900929&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CH612195(A5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CH612195A5 publication Critical patent/CH612195A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fodder In General (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1675474A 1973-12-17 1974-12-17 CH612195A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2362539A DE2362539C2 (de) 1973-12-17 1973-12-17 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CH612195A5 true CH612195A5 (xx) 1979-07-13

Family

ID=5900929

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1675474A CH612195A5 (xx) 1973-12-17 1974-12-17
CH1154378A CH620442A5 (xx) 1973-12-17 1978-11-09
CH1154278A CH621788A5 (xx) 1973-12-17 1978-11-09

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH1154378A CH620442A5 (xx) 1973-12-17 1978-11-09
CH1154278A CH621788A5 (xx) 1973-12-17 1978-11-09

Country Status (35)

Country Link
US (1) US4001411A (xx)
JP (1) JPS5826352B2 (xx)
AR (2) AR208527A1 (xx)
AT (1) AT346334B (xx)
BE (1) BE823400A (xx)
CA (1) CA1036606A (xx)
CH (3) CH612195A5 (xx)
CS (1) CS241002B2 (xx)
DD (1) DD115908A5 (xx)
DE (1) DE2362539C2 (xx)
DK (1) DK141845C (xx)
ES (2) ES432974A1 (xx)
FI (1) FI59594C (xx)
FR (1) FR2254343B1 (xx)
GB (1) GB1441554A (xx)
GR (1) GR60708B (xx)
GT (1) GT197850798A (xx)
HK (1) HK13379A (xx)
HU (1) HU170858B (xx)
IE (1) IE40124B1 (xx)
IL (1) IL46162A (xx)
IN (1) IN139511B (xx)
IT (1) IT7851978A0 (xx)
KE (1) KE2946A (xx)
LU (1) LU71204A1 (xx)
NL (1) NL185406C (xx)
NO (1) NO142304C (xx)
OA (1) OA04868A (xx)
PH (1) PH14220A (xx)
PL (3) PL99088B1 (xx)
RO (1) RO66907A (xx)
SE (1) SE422211B (xx)
SU (3) SU631070A3 (xx)
YU (1) YU41288B (xx)
ZA (1) ZA747253B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196291A (en) * 1973-12-17 1980-04-01 Merck Patent Gesellschaft Mit Beschraenkter Haftung 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4141978A (en) * 1973-12-17 1979-02-27 Merck Patent Gesellschaft Mit Beschrankter Haftung 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
DE2441261A1 (de) * 1974-08-28 1976-03-18 Merck Patent Gmbh Ringsubstituierte pyrazino-isochinolin-derivat und verfahren zu ihrer herstellung
US4162319A (en) * 1974-08-28 1979-07-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Ring substituted pyrazino-isoquinoline derivatives and their preparation
US4120961A (en) * 1974-08-28 1978-10-17 E. Merck Ring substituted pyrazino-isoquinoline derivatives and their preparation
DE2841668A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Medikiertes tierfutter auf basis lebermehl
US4303659A (en) * 1979-08-22 1981-12-01 Pfizer Inc. Schistosomicidal compositions
FR2520740A1 (fr) * 1982-01-29 1983-08-05 Sanofi Sa Procede pour la preparation d'acyl-2-hexahydro-1,3,4,6,7,11b-2h-pyrazino (2,1-a) isoquinoleinones-4 et intermediaires
DE3472678D1 (de) * 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NZ247278A (en) * 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US6429211B1 (en) 2000-05-23 2002-08-06 Bayer Corporation Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
RU2266906C1 (ru) * 2004-04-29 2005-12-27 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
KR100682506B1 (ko) * 2005-01-18 2007-02-15 (주)젠크로스 프라지콴텔, 또는 이의 염을 포함하는 약학 조성물
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
MX2007015729A (es) * 2005-06-09 2008-02-21 Schering Plough Ltd Control de parasitos en animales con derivados de n-[(feniloxi)fenil]-1,1,1-trifluorometansulfonamida y de n[(fenilsulfanil)fenil]-1,1,1-trifluorometansulfonamida.
FR2912145B1 (fr) * 2007-02-02 2009-03-06 Servier Lab Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ITPD20070274A1 (it) * 2007-08-08 2009-02-09 Sanypet S P A Crocchetta per animali e metodo per la sua produzione
ES2748136T3 (es) 2007-10-15 2020-03-13 United Animal Health Inc Método para aumentar el rendimiento de las crías
DE102008022520A1 (de) 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
CN102093346B (zh) * 2010-03-16 2012-09-05 浙江金伯士药业有限公司 一种吡喹酮的制备方法
US8889687B2 (en) 2011-03-04 2014-11-18 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
CN103910725B (zh) * 2013-01-09 2015-12-02 江南大学 一类吡喹酮类似物、其制备方法和用途

Also Published As

Publication number Publication date
SE422211B (sv) 1982-02-22
AR208715A1 (es) 1977-02-28
OA04868A (fr) 1980-10-31
FI59594C (fi) 1981-09-10
DD115908A5 (xx) 1975-10-20
ES441546A1 (es) 1977-04-16
CH621788A5 (xx) 1981-02-27
PL94074B1 (xx) 1977-07-30
RO66907A (ro) 1981-06-26
DE2362539C2 (de) 1986-05-07
IN139511B (xx) 1976-06-26
PL99088B1 (pl) 1978-06-30
BE823400A (fr) 1975-06-16
YU41288B (en) 1987-02-28
IE40124B1 (en) 1979-03-14
AR208527A1 (es) 1977-02-15
SU668603A3 (ru) 1979-06-15
HK13379A (en) 1979-03-23
HU170858B (hu) 1977-09-28
JPS5826352B2 (ja) 1983-06-02
NL7416432A (nl) 1975-06-19
DK141845B (da) 1980-06-30
SE7415686L (xx) 1975-06-18
FI363274A (xx) 1975-06-18
DK654274A (xx) 1975-08-25
CS241002B2 (en) 1986-03-13
FR2254343B1 (xx) 1978-06-30
LU71204A1 (xx) 1975-04-17
SU631070A3 (ru) 1978-10-30
GB1441554A (en) 1976-07-07
CH620442A5 (xx) 1980-11-28
FR2254343A1 (xx) 1975-07-11
CA1036606A (en) 1978-08-15
DE2362539A1 (de) 1975-08-28
IL46162A0 (en) 1975-02-10
NO142304B (no) 1980-04-21
IL46162A (en) 1979-01-31
ES432974A1 (es) 1977-02-16
DK141845C (da) 1980-12-22
ATA996274A (de) 1978-03-15
ZA747253B (en) 1975-11-26
GR60708B (en) 1978-07-24
CS842774A2 (en) 1985-06-13
SU625613A3 (ru) 1978-09-25
IT7851978A0 (it) 1978-11-20
JPS5093999A (xx) 1975-07-26
NL185406B (nl) 1989-11-01
NO142304C (no) 1980-07-30
FI59594B (fi) 1981-05-29
KE2946A (en) 1979-04-12
PH14220A (en) 1981-04-02
AU7643874A (en) 1976-06-17
US4001411A (en) 1977-01-04
NO744521L (xx) 1975-07-14
IE40124L (en) 1975-06-17
PL99105B1 (pl) 1978-06-30
NL185406C (nl) 1990-04-02
GT197850798A (es) 1979-08-01
AT346334B (de) 1978-11-10
YU336174A (en) 1983-01-21

Similar Documents

Publication Publication Date Title
AU476761B2 (xx)
AU474593B2 (xx)
AU474511B2 (xx)
FR2254343B1 (xx)
AU474838B2 (xx)
AU476714B2 (xx)
AU476696B2 (xx)
AU472848B2 (xx)
AU477823B2 (xx)
AU476873B1 (xx)
AU477824B2 (xx)
AR196382A1 (xx)
AU471461B2 (xx)
AU7594774A (xx)
CH238174A4 (xx)
BG19331A1 (xx)
AU479562A (xx)
AU479539A (xx)
AU479522A (xx)
AU479521A (xx)
AU479504A (xx)
AU479496A (xx)
AU479453A (xx)
AU479420A (xx)
BG18721A1 (xx)

Legal Events

Date Code Title Description
PL Patent ceased